Abstract:Benzodiazepines and zolpidem are generally prescribed as sedative, hypnotics, anxiolytics or anticonvulsants. These drugs, however, are frequently misused in drug-facilitated crime. Therefore, a rapid and simple liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed for identification and quantification of benzodiazepines, zolpidem and their metabolites in urine using deuterium labeled internal standards (IS). Urine samples (120 μL) mixed with 80 μL of the IS solution were centrifuged. An aliquot (5 μL) of the sample solution was directly injected into the LC-MS/MS system for analysis. The mobile phases consisted of water and acetonitrile containing 2mM ammonium trifluoroacetate and 0.2% acetic acid. The analytical column was a Zorbax SB-C18 (100 mm × 2.1 mm i.d., 3.5 μm, Agilent). The separation and detection of 18 analytes were achieved within 10 min. Calibration curves were linear over the concentration ranges of 0.5-20 ng/mL (zolpidem), 1.0-40 ng/mL (flurazepam and temazepam), 2.5-100 ng/mL (7-aminoclonazepam, 1-hydroxymidazolam, midazolam, flunitrazepam and alprazolam), 5.0-200 ng/mL (zolpidem phenyl-4-carboxylic acid, α-hydroxyalprazolam, oxazepam, nordiazepam, triazolam, diazepam and α-hydroxytriazolam), 10-400 ng/mL (lorazepam and desalkylflurazepam) and 10-100 ng/mL (N-desmethylflunitrazepam) with the coefficients of determination (r(2)) above 0.9971. The dilution integrity of the analytes was examined for supplementation of short linear range. Dilution precision and accuracy were tested using two, four and ten-folds dilutions and they ranged from 3.7 to 14.4% and -12.8 to 12.5%, respectively. The process efficiency for this method was 63.0-104.6%. Intra- and inter-day precisions were less than 11.8% and 9.1%, while intra- and inter-day accuracies were less than -10.0 to 8.2%, respectively. The lower limits of quantification were lower than 10 ng/mL for each analyte. The applicability of the developed method was successfully verified with human urine samples from drug users (n=21). Direct urine sample injection and optimized mobile phases were introduced for simple sample preparation and high-sensitivity with the desired separation.

High-throughput and Trace Analysis of Diazepam in Plasma Using DART-MS/MS and Its Pharmacokinetic Application.

Direct Analysis in Real Time Mass Spectrometry and Multivariate Data Analysis: a Novel Approach to Rapid Identification of Analytical Markers for Quality Control of Traditional Chinese Medicine Preparation.

Development and Validation of an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Quantitative Determination of N-((3S,4S)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)benzamide in Dog Plasma

Direct determination of diazepam and its glucuronide metabolites in human whole blood by μElution solid-phase extraction and liquid chromatography–tandem mass spectrometry

Extending the Detection Window of Diazepam by Directly Analyzing Its Glucuronide Metabolites in Human Urine Using Liquid Chromatography–tandem Mass Spectrometry

Restricted Access Magnetic Core-Mesoporous Shell Microspheres with C8-modified Interior Pore-Walls for the Determination of Diazepam in Rat Plasma by LC-MS.

Sensitive, Automatic Method for the Determination of Diazepam and Its Five Metabolites in Human Oral Fluid by Online Solid-Phase Extraction and Liquid Chromatography with Tandem Mass Spectrometry.

Determination Of Tranquilizer And Their Metabolites Residues In Aquatic Products By High Performance Liquid Chromatography-Tandem Mass Spectrometry

Simultaneous determination of amiodarone, dronedarone, and their principal metabolites in SD rat plasma by UPLC-MS/MS and its application in pharmacokinetics

Rapid Process Development of Chromatographic Process Using Direct Analysis in Real Time Mass Spectrometry As a Process Analytical Technology Tool

Simultaneous determination of midazolam and 1'-hydroxymidazolam in rat plasma by protein precipitation and LC-MS: Application to pharmacokinetic study

Rapid determination of benzodiazepines, zolpidem and their metabolites in urine using direct injection liquid chromatography-tandem mass spectrometry

A High-Sensitivity Lc-Ms/Ms Method for the Determination of 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3, 3-Diphenylpropyl Ester Hydrochloride in Rat Plasma and Its Application to A Pharmacokinetics Study

DART-MS:A New Research Tool for Herbal Medicine Analysis

Quantification of Axitinib After Oral and Intravenous Administration in Rats by UPLC-MS/MS: Application to the Pharmacokinetic Study

Quantitative Detection of Ambroxol in Human Plasma Using HPLC-APCI-MS/MS: Application to a Pharmacokinetic Study

UPLC–MS/MS for the Determination of Azilsartan in Beagle Dog Plasma and Its Application in a Pharmacokinetics Study

Simultaneous Determination of Amlodipine and Bisoprolol in Rat Plasma by a Liquid Chromatography/tandem Mass Spectrometry Method and Its Application in Pharmacokinetic Study.

Rapid Screening of Abused Drugs by Direct Analysis in Real Time (DART) Coupled to Time-of-flight Mass Spectrometry (TOF-MS) Combined with Ion Mobility Spectrometry (IMS).

Determination the concentration of citalopram and its metabolites in rat plasma by ultra performance liquid chromatography-tandem mass spectrometry

Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Simultaneous Determination of Antipsychotic Drugs in Human Plasma and Its Application in Therapeutic Drug Monitoring